A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult population중국 성인 인구에서 폐렴구균 백신 접종률 및 접종 의사와 관련된 요인에 대한 서술적 검토Article Published on 2022-11-302024-08-24 Journal: Human vaccines & immunotherapeutics [Category] 폐렴구균 감염증, [키워드] 23-valent pneumococcal polysaccharide vaccine China Elderly population pneumococcal vaccine Pneumonia PPSV-23 Willingness
A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult populationPneumococcal Published on 2022-11-152024-09-04 Journal: Human vaccines & immunotherapeutics [Category] 대상포진, [키워드] 23-valent pneumococcal polysaccharide vaccine China Elderly population pneumococcal vaccine Pneumonia PPSV-23 Willingness [DOI] 10.1080/21645515.2022.2139123 PMC 바로가기 [Article Type] Pneumococcal
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial중국에서 4가 스플릿-비리온 비활성화 인플루엔자 백신 및 23가 폐렴구균 다당류 백신과 함께 투여된 비활성화 SARS-CoV-2 백신(Sinopharm BBIBP-CorV)의 면역원성 및 안전성: 다기관, 비열등성, 공개 라벨, 무작위, 통제, 4상 시험Clinical Trial Published on 2022-08-262022-09-12 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] 23-valent pneumococcal polysaccharide vaccine Administered antibody assigned BBIBP-CorV block randomization blood sample China Coadministration Community dose eligible GMC GMT GMT ratio had no IgG antibody immunogenicity inactivated Inactivated SARS-CoV-2 vaccine individual Influenza Influenza virus multicentre non-inferiority Open-label participant per-protocol population pneumococcal Pneumonia polysaccharide polysaccharide vaccine randomised randomised controlled trial Randomly recruited Registered Safe SARS-CoV-2 SARS-CoV-2 neutralising antibody SARS-CoV-2 vaccine seroconversion rate serotypes Sinopharm Split-virion inactivated influenza vaccine. strain stratified Streptococcus pneumoniae the SARS-CoV-2 three group Trial vaccination Vaccine vaccine group [DOI] 10.1016/j.vaccine.2022.07.033 PMC 바로가기 [Article Type] Clinical Trial
Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50-69 years중국 50-69세의 인플루엔자, 폐렴 및 대상포진 예방접종에 대한 의지와 행동 간의 격차Article Published on 2021-09-012023-06-01 Journal: Expert review of vaccines [Category] 대상포진, 두창, 수두, 홍역, [키워드] 23-valent pneumococcal polysaccharide vaccine herpes zoster vaccine influenza vaccine Structural equation model vaccination willingness Vaccine hesitancy [DOI] 10.1080/14760584.2021.1954910
Safety and Efficacy of Simultaneous Inoculations of Pneumococcal and Influenza Vaccines in Patients with Coronary Artery Disease관상동맥 질환 환자에서 폐렴구균 및 인플루엔자 백신의 동시 접종의 안전성 및 유효성Original Article Published on 2021-08-012024-08-23 Journal: Journal of Atherosclerosis and Thrombosis [Category] 폐렴구균 감염증, [키워드] 23-valent pneumococcal polysaccharide vaccine Coronary artery disease Inflammation influenza vaccine oxidized low-density lipoprotein [DOI] 10.5551/jat.58297 PMC 바로가기 [Article Type] Original Article
[Effectiveness of 23-valent pneumococcal polysaccharide vaccine on adult pneumococcal disease]성인 폐렴구균 질환에 대한 23가 폐렴구균 다당류 백신의 효과Article Published on 2020-09-062024-08-24 Journal: Zhonghua Yu Fang Yi Xue Za Zhi [Category] 폐렴구균 감염증, [키워드] 23-valent pneumococcal polysaccharide vaccine adult vaccination Disease burden Streptococcus pneumoniae
Factors associated with pneumococcal vaccine uptake in elderly subjects referred to the respiratory departmentArticle Published on 2020-08-312024-09-07 Journal: Nagoya J Med Sci [Category] 폐렴구균 감염증, [키워드] 23-valent pneumococcal polysaccharide vaccine community-acquired pneumonia pneumococcal vaccine Streptococcus pneumonia PMC 바로가기
A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderlyarticle Published on 2019-12-312024-09-01 Journal: Human vaccines & immunotherapeutics [Category] 폐렴구균 감염증, [키워드] 23-valent pneumococcal polysaccharide vaccine immunogenicity Phase III Clinical Trial Safety [Article Type] article
The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease폐렴구균 면역화가 중증 만성 신장 질환 환자의 총 및 항원 특이적 B 세포에 미치는 영향Research Article Published on 2019-11-122024-07-28 Journal: BMC Immunology [Category] 폐렴구균 감염증, [키워드] 13-valent pneumococcal conjugate vaccine 23-valent pneumococcal polysaccharide vaccine B cells Chronic kidney disease CKD ELISPOT enzyme-linked immunospot assay flow cytometry memory B cells PCV13 PPV23 Streptococcus pneumoniae T-cell dependent response T-cell independent response [DOI] 10.1186/s12865-019-0325-9 PMC 바로가기 [Article Type] Research Article
Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderlyarticle Published on 2018-12-312024-09-01 Journal: Human vaccines & immunotherapeutics [Category] 폐렴구균 감염증, [키워드] 23-valent pneumococcal polysaccharide vaccine immunogenicity revaccination time interval [Article Type] article